Crinetics Pharmaceuticals, Inc

(NASDAQ:CRNX)

Latest On Crinetics Pharmaceuticals, Inc (CRNX):

Date/Time Type Description Signal Details
2023-05-25 19:43 ESTNewsCrinetics Pharmaceuticals And Its Value Proposition In AcromegalyN/A
2023-05-04 23:54 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43MN/A
2023-03-06 12:48 ESTNewsEvaluating Crinetics' Oral Long Shot For AcromegalyN/A
2023-02-28 18:44 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41MN/A
2022-12-30 22:15 ESTNewsCrinetics: FY23 Could Be Turning Point With Two Phase 3 Acromegaly ReadoutsN/A
2022-11-29 04:07 ESTNewsCrinetics says FDA didn’t clear Phase 2 study request for hyperinsulinism drugN/A
2022-11-15 00:39 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.78 beats by $0.03, revenue of $0.46M beats by $0.26MN/A
2022-08-12 17:31 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28MN/A
2022-06-13 22:31 ESTNewsCrinetics: Late-Stage Acromegaly Disease Studies Will Be Major Inflection PointN/A
2022-05-25 15:30 ESTNewsCrinetics hormone CRN04894 therapy shows promise in early-stage studyN/A
2022-05-13 09:56 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.73 misses by $0.17, revenue of $3.13M misses by $2.07MN/A
2022-04-29 23:10 ESTNewsCrinetics: An Orphan Disease Innovator On The RiseN/A
2022-04-24 11:40 ESTNewsCrinetics Pharmaceuticals: Endocrinology Focus To Pay Off As Multi-Faceted Pipeline Makes ProgressN/A
2022-04-13 16:17 ESTNewsCrinetics Pharmaceuticals prices $125M stock offeringN/A
2022-04-01 04:52 ESTNewsCrinetics stock gains on hyperinsulinism candidate's trial data; JMP raises PTN/A
2022-03-31 09:08 ESTNewsCrinetics Pharmaceuticals reports resultsN/A
2022-03-30 16:39 ESTNewsCrinetics shows dose-dependent effect of hyperinsulinism candidate in early trialN/A
2022-03-18 16:25 ESTNewsCrinetics delays early Phase 1 data for experimental therapy due to COVID-19N/A
2022-02-28 09:07 ESTNewsCrinetics, Sanwa ink licensing deal for cancer/hormonal disorder drug in JapanN/A
2021-10-22 05:14 ESTNewsCrinetics Pharmaceuticals prices $150M in stock offeringN/A
2021-10-21 03:29 ESTNewsCrinetics drops after announcing common stock offeringN/A
2021-09-21 15:29 ESTNewsCrinetics posts preliminary results from early-stage CRN04777 hyperinsulinism studyN/A
2021-09-21 15:23 ESTNewsCrinetics Pharmaceuticals (CRNX) Investor Presentation - SlideshowN/A
2021-09-02 17:30 ESTNewsCrinetics Pharmaceuticals names Jeff Knight as chief operating officerN/A
2021-08-10 23:06 ESTNewsCrinetics Pharmaceuticals posts positive data from early-stage CRN04894 trialN/A
2021-08-10 23:05 ESTNewsCrinetics Pharmaceuticals EPS misses by $0.10N/A
2021-07-29 16:43 ESTNewsCrinetics Pharmaceuticals proposes $15M in private placement with Frazier HealthcareN/A
2021-07-21 02:52 ESTNewsCrinetics doses first patient in late-stage oral paltusotine acromegaly trialN/A
2021-05-07 06:27 ESTNewsCrinetics Pharmaceuticals EPS misses by $0.04N/A
2021-04-08 07:33 ESTNewsCrinetics Pharma raises $75M via equity offeringN/A
2021-03-30 23:41 ESTNewsCrinetics Pharmaceuticals, Inc. (CRNX) CEO Scott Struthers on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-30 23:41 ESTNewsCrinetics Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-01-23 04:21 ESTNewsCrinetics Pharmaceuticals (CRNX) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2020-12-13 03:42 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 07:37 ESTAnalyst RatingThe Analyst Target Price has increased from $32.8 to $33.6.Buy
2020-11-09 11:40 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 11:40 ESTEarnings EstimateAn EPS average of -$0.59 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-07 15:30 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 06:16 ESTNewsCrinetics Pharmaceuticals EPS misses by $0.03N/A
2020-10-30 12:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $36.75 to $32.8.Neutral
2020-10-26 14:41 ESTNewsCrinetics Pharma lead drug successful in mid-stage acromegaly studyN/A
2020-09-26 12:27 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-08 04:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $36.8 to $36.75.Neutral
2020-09-05 01:11 ESTNewsCrinetics Pharma to advance ACTH antagonist candidate into the clinicN/A
2020-09-05 00:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-02 11:29 ESTNewsCrinetics Pharmaceuticals- Superior Molecules In EndocrinologyN/A
2020-08-09 08:28 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 16:03 ESTNewsCrinetics Pharmaceuticals EPS beats by $0.02N/A
2020-07-31 00:39 ESTFinancialsCompany financials have been released.Neutral

About Crinetics Pharmaceuticals, Inc (CRNX):

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, which is in Phase I clinical trials used for the treatment of acromegaly and neuroendocrine tumors. The company is also developing CRN01941, an oral selective nonpeptide sst2 biased agonist designed for the treatment of neuroendocrine tumors; an oral selective nonpeptide somatostatin type 5 receptor agonist for treating congenital hyperinsulinism; and an oral adrenocorticotrophic hormone antagonist for the treatment of cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

CRNX Quotes by TradingView

See Advanced Chart

General

  • Name Crinetics Pharmaceuticals, Inc
  • Symbol CRNX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 68
  • Fiscal Year EndDecember
  • IPO Date2018-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.crinetics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 1102.47
  • Price/Book (Most Recent Quarter) 2.99
  • Enterprise Value Revenue 961.96
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.55
  • Operating Margin -17443%
  • Return on Assets -25%
  • Return on Equity -42%
  • Revenue 392000
  • Earnings Per Share -$1.62
  • Revenue Per Share $0.01
  • Gross Profit -40313000
  • Quarterly Earnings Growth -80.7%
View More

Highlights

  • Market Capitalization 531.37 million
  • EBITDA -40113000
  • PE Ratio -16.43
  • Analyst Target Price $33.6
  • Book Value Per Share $5.69
View More

Share Statistics

  • Shares Outstanding 32.92 million
  • Shares Float 20.69 million
  • % Held by Insiders 450%
  • % Held by Institutions 95.14%
  • Shares Short 1.53 million
  • Shares Short Prior Month 1.38 million
  • Short Ratio 13.29
  • Short % of Float 6%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 1.23
  • 52 Week High $23.7
  • 52 Week Low $11.61
  • 50 Day Moving Average 15.77
  • 200 Day Moving Average 14.69
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Crinetics Pharmaceuticals, Inc (CRNX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Crinetics Pharmaceuticals, Inc (CRNX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-06$N/A-$0.56-$0.53-6.38%
2020-06-302020-08-07$N/A-$0.53-$0.554.21%
2020-03-312020-05-08$N/A-$0.71-$0.63-12.66%
2019-12-312020-03-09$321000-$0.60-$0.6811.35%
2019-09-302019-11-12$505000-$0.60-$0.54-11.92%
2019-06-302019-08-13$N/A-$0.51-$0.46-11.79%
2019-03-312019-05-13$367000-$0.37-$0.394.61%
2018-12-312019-03-13$781000-$0.35-$0.4115.09%
2018-09-302018-11-13$548000-$0.38-$0.34-10.47%
2018-06-302018-08-30$657000-$0.33-$0.31-7.32%

Crinetics Pharmaceuticals, Inc (CRNX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A N/A N/A 11.82 million
Income Before Tax N/A N/A N/A -14.55 million -14.43 million
Selling General Administrative N/A N/A N/A 3.39 million 3.91 million
Gross Profit N/A N/A N/A -11.82 million 505000
Ebit N/A N/A N/A -15.21 million -15.23 million
Operating Income N/A N/A N/A -15.21 million -15.23 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A 321000 505000
Cost of Revenue N/A N/A N/A 12.14 million N/A
Total Other Income Expense Net N/A N/A N/A 665000 799000
Net Income From Continuing Operations N/A N/A N/A -14.55 million -14.43 million
Net Income Applicable to Common Shares -18.32 million -16.49 million -17.36 million -14.55 million -14.43 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A -12.8 million 20.45 million
Change to Liabilities -752000 -831000 2.39 million 674000 114000
Total Cash Flow from Investing Activities -24.83 million 17.6 million 16.34 million -12.82 million 20.45 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A 17000 22000
Change to Operating Activities -2.04 million -1.25 million 491000 -1.47 million -1.11 million
Change in Cash N/A N/A N/A -26.25 million 6.86 million
Total Cash from Operating Activities -18 million -15.86 million -12.23 million -13.45 million -13.61 million
Depreciation N/A N/A N/A 229000 228000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 2.86 million 2.48 million 2.01 million 1.66 million 1.59 million
Capital Expenditures N/A N/A N/A 28000 N/A
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A N/A 13.24 million 12.99 million
Total Stockholder Equity N/A N/A N/A 117.14 million 129.52 million
Other Current Liabilities 810000 N/A N/A N/A N/A
Total Assets N/A N/A N/A 130.38 million 142.51 million
Common Stock 333.15 million 330.3 million 219.43 million 210.79 million 208.58 million
Other Current Assets N/A N/A N/A 2.48 million N/A
Retained Earnings -145.97 million -127.65 million -111.16 million -93.8 million -79.25 million
Other Liabilities 28000 34000 39000 49000 60000
Other Assets 500000 500000 500000 582000 500000
Cash N/A N/A N/A 40.33 million 66.58 million
Total Current Liabilities 8.83 million N/A N/A 8.34 million 7.88 million
Other Stockholder Equity 44000 127000 167000 148000 198000
Property, Plant & Equipment 5.7 million 6.01 million 6.22 million 6.46 million 6.61 million
Total Current Assets 194.12 million N/A N/A 123.34 million 135.4 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 187.22 million 202.77 million 108.44 million 117.14 million 129.52 million
Short Term Investments N/A N/A N/A 78.07 million 65.09 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 4.69 million N/A N/A 2.7 million 2.11 million

Crinetics Pharmaceuticals, Inc (CRNX) Chart:

Crinetics Pharmaceuticals, Inc (CRNX) News:

Below you will find a list of latest news for Crinetics Pharmaceuticals, Inc (CRNX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Crinetics Pharmaceuticals, Inc (CRNX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-10-17200CALL0 0225.61TRUE00
2025-10-17210CALL0 0210.57TRUE00
2025-10-17220CALL0 0196.16TRUE00
2025-10-17230CALL0 0182.3TRUE00
2025-10-17240CALL0 0168.91TRUE00
2025-10-17250CALL0 0155.87TRUE00
2025-10-172617.8CALL0 2143.08TRUE00
2025-10-172716.6CALL0 3130.31TRUE00
2025-10-172813.7CALL0 4117.17TRUE00
2025-10-172912.37CALL0 5102.22TRUE00
2025-10-173011.5CALL0 330TRUE00
2025-10-173114.16CALL0 690TRUE00
2025-10-17329.7CALL0 70TRUE00
2025-10-173314CALL0 5155.25TRUE00
2025-10-173411CALL10 52109.27TRUE110
2025-10-173510.27CALL19 1156146.7TRUE-0.23-0.02
2025-10-17365.8CALL0 62118.7TRUE00
2025-10-17378.5CALL38 2687142.57TRUE-0.1-0.01
2025-10-17389CALL0 130TRUE00
2025-10-17395CALL0 1089.06TRUE00
2025-10-17404.8CALL41 6490TRUE-0.8-0.14
2025-10-17414.75CALL0 1036.17TRUE00
2025-10-17424CALL1 7399.71TRUE40
2025-10-17432.55CALL0 3162.72TRUE00
2025-10-17442.18CALL1 5672.88TRUE2.180
2025-10-17451.9CALL17 181383.55FALSE-0.1-0.05
2025-10-17461.45CALL0 17100.43FALSE00
2025-10-17471.22CALL0 2167.81FALSE00
2025-10-17481.25CALL0 6174.81FALSE00
2025-10-17490CALL0 0157.81FALSE00
2025-10-17500.5CALL61 91688.22FALSE-0.05-0.09
2025-10-17550.11CALL0 21175.36FALSE00
2025-10-17600.05CALL0 6277.15FALSE00
2025-10-17650.1CALL0 11317.01FALSE00
2025-10-17200.55PUT0 12284.67FALSE00
2025-10-17210PUT0 0625.7FALSE00
2025-10-17220PUT0 0594.93FALSE00
2025-10-17230PUT0 0565.65FALSE00
2025-10-17240PUT0 0537.71FALSE00
2025-10-17250.25PUT0 12299.72FALSE00
2025-10-17260PUT0 0485.3FALSE00
2025-10-17271.7PUT0 3460.6FALSE00
2025-10-17281.25PUT0 9250.4FALSE00
2025-10-17290.05PUT0 147163.53FALSE00
2025-10-17300.05PUT0 1045152.31FALSE00
2025-10-17310PUT0 0369.71FALSE00
2025-10-17320PUT0 0348.59FALSE00
2025-10-17330.05PUT0 58242.51FALSE00
2025-10-17340.1PUT0 18307.8FALSE00
2025-10-17350.25PUT0 85100.37FALSE00
2025-10-17360PUT0 0268.56FALSE00
2025-10-17370.55PUT0 6249.36FALSE00
2025-10-17380.71PUT0 38111.76FALSE00
2025-10-17390.4PUT0 14214.17FALSE00
2025-10-17400.39PUT0 50202.96FALSE00
2025-10-17411.3PUT0 18181.14FALSE00
2025-10-17422.5PUT0 32112.87FALSE00
2025-10-17431.4PUT20 5199.89FALSE0.20.17
2025-10-17443PUT0 28143.41FALSE00
2025-10-17452.25PUT0 7964.31TRUE00
2025-10-17463.05PUT0 184.33TRUE00
2025-10-17470PUT0 075.3TRUE00
2025-10-17480PUT0 077.59TRUE00
2025-10-17490PUT0 079.6TRUE00
2025-10-17509.15PUT0 1078.51TRUE00
2025-10-17550PUT0 0106.08TRUE00
2025-10-17600PUT0 00TRUE00
2025-10-17650PUT0 00TRUE00
2025-11-21200CALL0 00TRUE00
2025-11-21250CALL0 057.06TRUE00
2025-11-21260CALL0 076.13TRUE00
2025-11-21270CALL0 070.37TRUE00
2025-11-21280CALL0 00TRUE00
2025-11-212912.92CALL0 668.25TRUE00
2025-11-213012.11CALL0 568.74TRUE00
2025-11-21310CALL0 063.57TRUE00
2025-11-21320CALL0 062.72TRUE00
2025-11-213312CALL0 261.07TRUE00
2025-11-21348.41CALL0 158.87TRUE00
2025-11-21358.3CALL0 160.68TRUE00
2025-11-213610.48CALL0 160.88TRUE00
2025-11-21379.7CALL0 2161.54TRUE00
2025-11-21380CALL0 061.1TRUE00
2025-11-21396.9CALL0 259.86TRUE00
2025-11-21406CALL0 5562.2TRUE00
2025-11-21413.9CALL0 460.4TRUE00
2025-11-21423.7CALL0 462.62TRUE00
2025-11-21435CALL0 462.97TRUE00
2025-11-21442.25CALL0 2262.13TRUE00
2025-11-21453.8CALL0 7364.37FALSE00
2025-11-21462.15CALL0 163.38FALSE00
2025-11-21472.24CALL0 663.4FALSE00
2025-11-21483.6CALL0 1562.78FALSE00
2025-11-21490CALL0 063.23FALSE00
2025-11-21502.1CALL15 4264.44FALSE-0.3-0.13
2025-11-21551.45CALL0 19106.64FALSE00
2025-11-21600CALL0 0118.94FALSE00
2025-11-21650CALL0 0122.63FALSE00
2025-11-21200PUT0 0252.71FALSE00
2025-11-21250.11PUT0 1198.15FALSE00
2025-11-21260PUT0 0188.27FALSE00
2025-11-21270PUT0 0178.76FALSE00
2025-11-21280PUT0 0171.14FALSE00
2025-11-21290PUT0 0162.22FALSE00
2025-11-21300PUT0 0155.01FALSE00
2025-11-21310PUT0 0146.56FALSE00
2025-11-21320PUT0 0139.66FALSE00
2025-11-21330.8PUT0 1170.95FALSE00
2025-11-21340PUT0 0124.93FALSE00
2025-11-21351.1PUT0 14968.07FALSE00
2025-11-21361.25PUT0 200114.04FALSE00
2025-11-21371.5PUT0 203109.59FALSE00
2025-11-21381.35PUT0 151104.98FALSE00
2025-11-21390PUT0 0105.18FALSE00
2025-11-21403PUT0 872.73FALSE00
2025-11-21410PUT0 098.44FALSE00
2025-11-21420PUT0 061.6FALSE00
2025-11-21430PUT0 060.72FALSE00
2025-11-21440PUT0 060.42FALSE00
2025-11-21454.4PUT0 1260.63TRUE00
2025-11-21460PUT0 061.37TRUE00
2025-11-21470PUT0 060.57TRUE00
2025-11-21480PUT0 062.04TRUE00
2025-11-21490PUT0 062.5TRUE00
2025-11-21509.6PUT0 161.45TRUE00
2025-11-21550PUT0 062.91TRUE00
2025-11-21600PUT0 068.79TRUE00
2025-11-21650PUT0 081.9TRUE00
2025-12-19150CALL0 00TRUE00
2025-12-19170CALL0 00TRUE00
2025-12-19180CALL0 00TRUE00
2025-12-19190CALL0 00TRUE00
2025-12-19200CALL0 070.72TRUE00
2025-12-19210CALL0 00TRUE00
2025-12-19220CALL0 074.49TRUE00
2025-12-192310.2CALL0 168.49TRUE00
2025-12-19240CALL0 062.57TRUE00
2025-12-192517CALL0 1856.62TRUE00
2025-12-192616.02CALL0 361.61TRUE00
2025-12-192715CALL0 367.26TRUE00
2025-12-192814CALL0 162.54TRUE00
2025-12-192913.5CALL0 564.56TRUE00
2025-12-193016.3CALL0 4962.62TRUE00
2025-12-19312.6CALL0 162.56TRUE00
2025-12-193214.2CALL0 10763.51TRUE00
2025-12-193310CALL0 1160.47TRUE00
2025-12-19345.05CALL0 1161.5TRUE00
2025-12-19357.8CALL0 60159.23TRUE00
2025-12-19363.98CALL0 561.08TRUE00
2025-12-19379.6CALL15 2161TRUE9.60
2025-12-19380CALL0 060.35TRUE00
2025-12-19390CALL0 060.05TRUE00
2025-12-19407.1CALL0 20760.01TRUE00
2025-12-19410CALL0 060.19TRUE00
2025-12-19424.52CALL0 361.25TRUE00
2025-12-19435.2CALL0 260.41TRUE00
2025-12-19440CALL0 061.14TRUE00
2025-12-19455CALL0 12054.25FALSE00
2025-12-19460CALL0 063.15FALSE00
2025-12-19472.7CALL0 162.25FALSE00
2025-12-19480CALL0 061.6FALSE00
2025-12-19490CALL0 061.54FALSE00
2025-12-19502.95CALL15 8560.46FALSE2.950
2025-12-19551.3CALL0 13260.36FALSE00
2025-12-19601.37CALL1 2567.7FALSE1.370
2025-12-19650.8CALL505 31666.91FALSE0.80
2025-12-19700.8CALL0 9110.22FALSE00
2025-12-19750CALL0 1116.33FALSE00
2025-12-19800CALL0 0123.9FALSE00
2025-12-19850CALL0 0130.67FALSE00
2025-12-19900CALL0 0109.85FALSE00
2025-12-19150PUT0 0253.47FALSE00
2025-12-19170.25PUT0 12227.8FALSE00
2025-12-19180.4PUT0 1216.29FALSE00
2025-12-19190.55PUT0 1205.52FALSE00
2025-12-19200.6PUT0 14195.38FALSE00
2025-12-19210.85PUT0 1185.8FALSE00
2025-12-19220PUT0 0178.26FALSE00
2025-12-19230PUT0 0169.56FALSE00
2025-12-19240.15PUT0 1161.26FALSE00
2025-12-19252.05PUT0 6154.67FALSE00
2025-12-19261.85PUT0 1147FALSE00
2025-12-19270.05PUT0 0139.61FALSE00
2025-12-19280PUT0 0133.7FALSE00
2025-12-19292.6PUT0 6127.92FALSE00
2025-12-19302.9PUT0 12122.28FALSE00
2025-12-19312.36PUT0 6116.74FALSE00
2025-12-19325PUT0 5111.31FALSE00
2025-12-19330PUT0 0106.93FALSE00
2025-12-19340PUT0 0102.55FALSE00
2025-12-19351.25PUT0 5967.3FALSE00
2025-12-19364.2PUT0 195.44FALSE00
2025-12-19370PUT0 092.57FALSE00
2025-12-19381.7PUT0 2091.11FALSE00
2025-12-19390PUT0 060.53FALSE00
2025-12-19403.37PUT0 1158.24FALSE00
2025-12-19410PUT0 058.96FALSE00
2025-12-19420PUT0 057FALSE00
2025-12-19430PUT0 057.71FALSE00
2025-12-19440PUT0 057.25FALSE00
2025-12-19455.89PUT0 5661.19TRUE00
2025-12-19460PUT0 059.46TRUE00
2025-12-19470PUT0 059.57TRUE00
2025-12-19480PUT0 061.21TRUE00
2025-12-19490PUT0 061.18TRUE00
2025-12-19509.63PUT0 061.45TRUE00
2025-12-19550PUT0 062.71TRUE00
2025-12-19600PUT0 063.08TRUE00
2025-12-19650PUT0 065.82TRUE00
2025-12-197028.2PUT0 070.48TRUE00
2025-12-19750PUT0 076.78TRUE00
2025-12-19800PUT0 076.63TRUE00
2025-12-19850PUT0 083.16TRUE00
2025-12-19900PUT0 00TRUE00
2026-01-161527CALL0 097.35TRUE00
2026-01-162021.7CALL0 1689.79TRUE00
2026-01-162517.1CALL0 1773.36TRUE00
2026-01-163015.8CALL0 19967.03TRUE00
2026-01-163512.1CALL2 262167.64TRUE12.10
2026-01-16360CALL0 067.57TRUE00
2026-01-16370CALL0 065.64TRUE00
2026-01-16380CALL0 066.29TRUE00
2026-01-16390CALL0 067.81TRUE00
2026-01-16406.4CALL0 4568.84TRUE00
2026-01-16416.4CALL0 29769.47TRUE00
2026-01-16425.7CALL0 870.32TRUE00
2026-01-16435.7CALL0 4670.27TRUE00
2026-01-16445.4CALL0 271.06TRUE00
2026-01-16456.5CALL32 6068.79FALSE-0.5-0.07
2026-01-16466.4CALL3 272.32FALSE6.40
2026-01-16470CALL0 070.66FALSE00
2026-01-16480CALL0 070.4FALSE00
2026-01-16495.1CALL5 070.45FALSE5.10
2026-01-16504.7CALL5 9969.73FALSE4.70
2026-01-16553.85CALL0 1167.29FALSE00
2026-01-16601.63CALL0 264463.62FALSE00
2026-01-16651CALL0 1576.94FALSE00
2026-01-16700.85CALL0 597.94FALSE00
2026-01-16750CALL0 082.68FALSE00
2026-01-16800CALL0 5107.82FALSE00
2026-01-16850CALL0 0113.65FALSE00
2026-01-16900CALL0 0118.91FALSE00
2026-01-16150PUT0 0214.21FALSE00
2026-01-16201.25PUT0 8166.6FALSE00
2026-01-16250.5PUT0 12131.99FALSE00
2026-01-16303.6PUT0 7106.31FALSE00
2026-01-16352.6PUT0 397.99FALSE00
2026-01-16360PUT0 067.58FALSE00
2026-01-16370PUT0 066.87FALSE00
2026-01-16380PUT0 066.88FALSE00
2026-01-16390PUT0 067.49FALSE00
2026-01-16403.65PUT4 6468.63FALSE3.650
2026-01-16410PUT0 066.95FALSE00
2026-01-16426PUT0 167.38FALSE00
2026-01-16430PUT0 069.19FALSE00
2026-01-16440PUT0 068.39FALSE00
2026-01-16450PUT0 068.44TRUE00
2026-01-16460PUT0 069.85TRUE00
2026-01-16470PUT0 068.82TRUE00
2026-01-16488PUT0 1469.16TRUE00
2026-01-16490PUT0 068.73TRUE00
2026-01-16509.8PUT0 3468.6TRUE00
2026-01-16550PUT0 066.84TRUE00
2026-01-16600PUT0 067.88TRUE00
2026-01-16650PUT0 066.73TRUE00
2026-01-16700PUT0 067.52TRUE00
2026-01-167533.8PUT0 071.3TRUE00
2026-01-16800PUT0 073.42TRUE00
2026-01-16850PUT0 075.47TRUE00
2026-01-16900PUT0 080.88TRUE00
2026-03-202022.4CALL0 381.32TRUE00
2026-03-20210CALL0 078.41TRUE00
2026-03-202221.8CALL0 577.32TRUE00
2026-03-20230CALL0 074.36TRUE00
2026-03-202422.35CALL0 571.45TRUE00
2026-03-20250CALL0 071.33TRUE00
2026-03-20260CALL0 070.78TRUE00
2026-03-20270CALL0 068.83TRUE00
2026-03-20286.9CALL0 1169.78TRUE00
2026-03-202916.5CALL0 270.17TRUE00
2026-03-203016.43CALL0 370.14TRUE00
2026-03-203114CALL0 170.53TRUE00
2026-03-203217.07CALL0 869.15TRUE00
2026-03-20334.6CALL0 169.62TRUE00
2026-03-20340CALL0 069.12TRUE00
2026-03-203514.2CALL0 369.58TRUE00
2026-03-203611.3CALL0 169.74TRUE00
2026-03-20379.95CALL0 269.11TRUE00
2026-03-203811CALL0 469.33TRUE00
2026-03-20390CALL0 068.31TRUE00
2026-03-20408.6CALL0 168.12TRUE00
2026-03-20410CALL0 067.73TRUE00
2026-03-20427.3CALL0 2767.62TRUE00
2026-03-20438.76CALL0 267.33TRUE00
2026-03-20446.1CALL0 6667.31TRUE00
2026-03-20458.29CALL5 7867.9FALSE8.290
2026-03-20465.4CALL0 1666.77FALSE00
2026-03-20475.3CALL0 4265.84FALSE00
2026-03-20485.1CALL0 1065.19FALSE00
2026-03-20495.7CALL0 565.24FALSE00
2026-03-20504.5CALL0 11962.62FALSE00
2026-03-20553.3CALL0 1264.57FALSE00
2026-03-20602.9CALL0 1271.06FALSE00
2026-03-20652.05CALL0 266.24FALSE00
2026-03-20200.85PUT0 1130.53FALSE00
2026-03-20211.1PUT0 1125.24FALSE00
2026-03-20220.95PUT0 0120.19FALSE00
2026-03-20231.5PUT0 2115.35FALSE00
2026-03-20241.65PUT0 2110.7FALSE00
2026-03-20251.9PUT0 3107.08FALSE00
2026-03-20262.25PUT0 2104.37FALSE00
2026-03-20271.5PUT0 1100.86FALSE00
2026-03-20282.95PUT0 198.16FALSE00
2026-03-20290PUT0 096.17FALSE00
2026-03-20304PUT0 194.1FALSE00
2026-03-20312.25PUT0 191.97FALSE00
2026-03-20322.45PUT0 066.3FALSE00
2026-03-20332.75PUT0 263.8FALSE00
2026-03-20340PUT0 065.1FALSE00
2026-03-20356.1PUT0 3164.48FALSE00
2026-03-20363.2PUT0 1964.2FALSE00
2026-03-20374PUT0 2673.3FALSE00
2026-03-20388.9PUT0 163.75FALSE00
2026-03-20390PUT0 063.81FALSE00
2026-03-20400PUT0 063.88FALSE00
2026-03-20410PUT0 063.95FALSE00
2026-03-20426.25PUT0 1064.05FALSE00
2026-03-20430PUT0 063.94FALSE00
2026-03-20440PUT0 063.64FALSE00
2026-03-20450PUT0 063.59TRUE00
2026-03-20460PUT0 063.8TRUE00
2026-03-20470PUT0 062.98TRUE00
2026-03-20480PUT0 062.85TRUE00
2026-03-20490PUT0 062.14TRUE00
2026-03-205012PUT0 1061.7TRUE00
2026-03-20550PUT0 062.39TRUE00
2026-03-20600PUT0 063.04TRUE00
2026-03-20650PUT0 064.54TRUE00

Latest CRNX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$17.17
Jun 13, 2022 7:59 PM EST100$17.19
Jun 13, 2022 7:59 PM EST1$17.17
Jun 13, 2022 7:59 PM EST100$17.2
Jun 13, 2022 7:59 PM EST100$17.2

Crinetics Pharmaceuticals, Inc (CRNX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm
2018-07-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1658247/000000000018021079/0000000000-18-021079-index.htm
2019-08-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1658247/000000000019012560/0000000000-19-012560-index.htm
2018-09-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000031506618002299/0000315066-18-002299-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000031506619000968/0000315066-19-000968-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000031506620000861/0000315066-20-000861-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019963/0000899243-18-019963-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019964/0000899243-18-019964-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019965/0000899243-18-019965-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019967/0000899243-18-019967-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019968/0000899243-18-019968-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019972/0000899243-18-019972-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019974/0000899243-18-019974-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019975/0000899243-18-019975-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019978/0000899243-18-019978-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019979/0000899243-18-019979-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm
2019-02-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924319003318/0000899243-19-003318-index.htm
2019-02-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924319003326/0000899243-19-003326-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm
2018-07-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000094787118000610/0000947871-18-000610-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000101297518000919/0001012975-18-000919-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm
2018-08-274/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000101297518001046/0001012975-18-001046-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918045567/0001104659-18-045567-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918045579/0001104659-18-045579-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918046292/0001104659-18-046292-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2018-07-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918048071/0001104659-18-048071-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919006113/0001104659-19-006113-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919008632/0001104659-19-008632-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919010154/0001104659-19-010154-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465920011470/0001104659-20-011470-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465920021136/0001104659-20-021136-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000114420419008307/0001144204-19-008307-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000117266120000650/0001172661-20-000650-index.htm
2018-07-128-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1658247/000119312518216421/0001193125-18-216421-index.htm
2018-07-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312518217820/0001193125-18-217820-index.htm
2018-07-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312518217824/0001193125-18-217824-index.htm
2018-07-17S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1658247/000119312518219860/0001193125-18-219860-index.htm
2018-07-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1658247/000119312518220701/0001193125-18-220701-index.htm
2018-07-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1658247/000119312518220704/0001193125-18-220704-index.htm
2018-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518222517/0001193125-18-222517-index.htm
2018-07-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1658247/000119312518231543/0001193125-18-231543-index.htm
2018-08-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1658247/000119312518259557/0001193125-18-259557-index.htm
2018-08-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518263610/0001193125-18-263610-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518289506/0001193125-18-289506-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518325476/0001193125-18-325476-index.htm
2019-08-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1658247/000119312519220012/0001193125-19-220012-index.htm
2019-08-19S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1658247/000119312519224488/0001193125-19-224488-index.htm
2019-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312519224495/0001193125-19-224495-index.htm
2019-08-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312519230761/0001193125-19-230761-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312520099551/0001193125-20-099551-index.htm
2020-04-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1658247/000119312520107151/0001193125-20-107151-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312520107156/0001193125-20-107156-index.htm
2020-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312520108092/0001193125-20-108092-index.htm
2020-04-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1658247/000119312520108096/0001193125-20-108096-index.htm
2020-04-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1658247/000119312520111625/0001193125-20-111625-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119018982/0001209191-19-018982-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119018983/0001209191-19-018983-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119018984/0001209191-19-018984-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038894/0001209191-19-038894-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038896/0001209191-19-038896-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038897/0001209191-19-038897-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038902/0001209191-19-038902-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038905/0001209191-19-038905-index.htm
2019-07-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119042285/0001209191-19-042285-index.htm
2019-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119042286/0001209191-19-042286-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2020-02-115Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120008269/0001209191-20-008269-index.htm
2020-02-115Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120008272/0001209191-20-008272-index.htm
2020-02-115Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120008280/0001209191-20-008280-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120012974/0001209191-20-012974-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120012987/0001209191-20-012987-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120012997/0001209191-20-012997-index.htm
2020-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120021372/0001209191-20-021372-index.htm
2020-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038153/0001209191-20-038153-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038161/0001209191-20-038161-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038166/0001209191-20-038166-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038172/0001209191-20-038172-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2020-09-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120049508/0001209191-20-049508-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120049518/0001209191-20-049518-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020003601/0001213900-20-003601-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-06-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020014709/0001213900-20-014709-index.htm
2018-07-12CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1658247/000135445718000250/0001354457-18-000250-index.htm
2018-08-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459018022504/0001564590-18-022504-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459018029304/0001564590-18-029304-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019007555/0001564590-19-007555-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1658247/000156459019007561/0001564590-19-007561-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019011511/0001564590-19-011511-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1658247/000156459019013719/0001564590-19-013719-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1658247/000156459019013723/0001564590-19-013723-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019018827/0001564590-19-018827-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459019018831/0001564590-19-018831-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019023431/0001564590-19-023431-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019025016/0001564590-19-025016-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019031797/0001564590-19-031797-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459019031801/0001564590-19-031801-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019042893/0001564590-19-042893-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459019042900/0001564590-19-042900-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000156459020004205/0001564590-20-004205-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020009362/0001564590-20-009362-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1658247/000156459020009365/0001564590-20-009365-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1658247/000156459020019202/0001564590-20-019202-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1658247/000156459020019210/0001564590-20-019210-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020023260/0001564590-20-023260-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459020023265/0001564590-20-023265-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020030117/0001564590-20-030117-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020038067/0001564590-20-038067-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459020038069/0001564590-20-038069-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020042431/0001564590-20-042431-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020044046/0001564590-20-044046-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020047499/0001564590-20-047499-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020051684/0001564590-20-051684-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459020051686/0001564590-20-051686-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000161577418006600/0001615774-18-006600-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2018-07-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000161577418006903/0001615774-18-006903-index.htm
2019-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1658247/999999999518001811/9999999995-18-001811-index.htm
2019-08-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1658247/999999999519002011/9999999995-19-002011-index.htm

Crinetics Pharmaceuticals, Inc (CRNX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crinetics Pharmaceuticals, Inc (CRNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 450%
Institutional Ownership: 9514%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-185AM Ventures IV, L.P.10% Share HolderSell6,194.0024.25150,208.84104,489.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2019-08-05Richard Scott StruthersPresident & CEOBuy10,000.001.9119,100.001,225,805.00https://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm
2019-12-16Matthew K FustDirectorSell3,500.0022.5078,750.0012,536.00https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2019-01-225AM Ventures IV, L.P.10% Share HolderSell10,486.0021.88229,381.25129,483.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2018-07-205AM Ventures IV, L.P.10% Share HolderBuy4,600.0017.0078,200.00139,969.00https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy141,177.0017.002,400,009.00141,177.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2019-12-16Matthew K FustDirectorBuy3,500.001.916,685.0016,036.00https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2020-03-09Vivo Capital VIII, LLC10% Share HolderSell133.0019.502,593.50168,165.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10Vivo Capital VIII, LLC10% Share HolderSell5,904.0021.40126,345.60168,298.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07Vivo Capital VIII, LLC10% Share HolderSell4,614.0022.00101,508.00174,202.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04Vivo Capital VIII, LLC10% Share HolderSell10,519.0022.80239,833.20178,816.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31Vivo Capital VIII, LLC10% Share HolderSell4,220.0021.7091,574.00189,335.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30Vivo Capital VIII, LLC10% Share HolderSell5,940.0022.10131,274.00193,555.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29Vivo Capital VIII, LLC10% Share HolderSell10,878.0022.20241,491.60199,495.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2018-07-20Alan Seth KrasnerChief Medical OfficerBuy2,000.0017.0034,000.002,000.00https://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm
2019-03-20Vivo Capital VIII, LLC10% Share HolderSell83,984.0022.251,868,644.00210,373.00https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2020-04-17Vivo Capital VIII, LLC10% Share HolderSell74,333.0015.401,144,728.202,162,587.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-04-16Vivo Capital VIII, LLC10% Share HolderSell26,527.0015.20403,210.402,236,920.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-04-15Vivo Capital VIII, LLC10% Share HolderSell189,625.0015.502,939,187.502,263,447.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2019-06-215AM Ventures IV, L.P.InsiderSell240,000.0022.205,328,000.002,267,797.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2018-07-20PERCEPTIVE ADVISORS LLCDirectorBuy400,000.0017.006,800,000.002,280,305.00https://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm
2020-04-07Vivo Capital VIII, LLC10% Share HolderSell5,373.0014.2076,296.602,453,072.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-03Vivo Capital VIII, LLC10% Share HolderSell263,600.0013.803,637,680.002,458,445.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2019-03-185AM Ventures IV, L.P.10% Share HolderSell148,645.0024.253,604,745.302,507,797.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2020-03-09Vivo Capital VIII, LLC10% Share HolderSell347.0019.506,766.502,722,045.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10Vivo Capital VIII, LLC10% Share HolderSell1,451.0021.4031,051.402,722,392.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07Vivo Capital VIII, LLC10% Share HolderSell1,134.0022.0024,948.002,723,843.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04Vivo Capital VIII, LLC10% Share HolderSell2,584.0022.8058,915.202,724,977.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31Vivo Capital VIII, LLC10% Share HolderSell1,037.0021.7022,502.902,727,561.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30Vivo Capital VIII, LLC10% Share HolderSell1,459.0022.1032,243.902,728,598.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29Vivo Capital VIII, LLC10% Share HolderSell2,673.0022.2059,340.602,730,057.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2019-03-20Vivo Capital VIII, LLC10% Share HolderSell292,609.0022.256,510,550.252,732,730.00https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy153,180.0020.733,175,421.40294,357.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-04-17Vivo Capital VIII, LLC10% Share HolderSell10,265.0015.40158,081.00298,625.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy51,686.0017.00878,662.003,025,339.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-04-16Vivo Capital VIII, LLC10% Share HolderSell3,663.0015.2055,677.60308,890.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2019-01-225AM Ventures IV, L.P.10% Share HolderSell251,667.0021.885,505,215.633,107,642.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2020-04-15Vivo Capital VIII, LLC10% Share HolderSell26,185.0015.50405,867.50312,553.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2018-07-205AM Ventures IV, L.P.10% Share HolderBuy110,400.0017.001,876,800.003,359,309.00https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2020-04-07Vivo Capital VIII, LLC10% Share HolderSell742.0014.2010,536.40338,738.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-03Vivo Capital VIII, LLC10% Share HolderSell36,400.0013.80502,320.00339,480.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-17PERCEPTIVE ADVISORS LLC10% Share HolderBuy1,071,428.0014.0014,999,992.003,659,381.00https://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm
2020-03-09Vivo Capital VIII, LLC10% Share HolderSell48.0019.50936.00375,880.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10Vivo Capital VIII, LLC10% Share HolderSell200.0021.404,280.00375,928.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07Vivo Capital VIII, LLC10% Share HolderSell157.0022.003,454.00376,128.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04Vivo Capital VIII, LLC10% Share HolderSell357.0022.808,139.60376,285.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31Vivo Capital VIII, LLC10% Share HolderSell143.0021.703,103.10376,642.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30Vivo Capital VIII, LLC10% Share HolderSell201.0022.104,442.10376,785.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29Vivo Capital VIII, LLC10% Share HolderSell369.0022.208,191.80376,986.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2019-03-20Vivo Capital VIII, LLC10% Share HolderSell40,407.0022.25899,055.75377,355.00https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy7,137.0017.00121,329.00417,762.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-07-16Richard Scott StruthersPresident & CEOSell17,500.0014.46253,107.75890,805.00https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2020-07-15Richard Scott StruthersPresident & CEOSell17,500.0015.30267,722.00908,305.00https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2019-06-215AM Ventures IV, L.P.InsiderSell10,000.0022.20222,000.0094,489.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2020-04-28WENDALL WIERENGADirectorBuy25,329.000.7318,490.1799,846.00https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm